Antigony Mitselou
About
In The Last Decade
Antigony Mitselou
29 papers receiving 386 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 165
- Oncology 92
- Endocrinology, Diabetes and Metabolism 57
- Cancer Research 48
- Surgery 43
Countries citing papers authored by Antigony Mitselou
This map shows the geographic impact of Antigony Mitselou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antigony Mitselou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antigony Mitselou more than expected).
Fields of papers citing papers by Antigony Mitselou
This network shows the impact of papers produced by Antigony Mitselou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antigony Mitselou. The network helps show where Antigony Mitselou may publish in the future.
Co-authorship network of co-authors of Antigony Mitselou
This figure shows the co-authorship network connecting the top 25 collaborators of Antigony Mitselou. A scholar is included among the top collaborators of Antigony Mitselou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antigony Mitselou. Antigony Mitselou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 40 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer. | 26 |
| 7 | Predictive role of thymidine phosphorylase expression in patients with colorectal cancer and its association with angiogenesis-related proteins and extracellular matrix components. | 14 |
| 8 | Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma. | 20 |
| 9 | Altered expression of cell cycle and apoptotic proteins in human liver pathologies. | 10 |
| 10 | 22 | |
| 11 | E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. | 28 |
| 12 | 2 | |
| 13 | 7 | |
| 14 | Churg-Strauss syndrome (allergic granulomatous angiitis) associated with T lymphoblastic lymphoma. | 3 |
| 15 | Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins. | 11 |
| 16 | Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. | 16 |
| 17 | Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters. | 7 |
| 18 | Angiotropic large cell lymphoma. | 2 |
| 19 | 3 | |
| 20 | Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1). | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.